Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase.

Podobne zapisy

• Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase.
  od: Keulen, W, i wsp.
  Wydane: (1997)
• Differential Removal of Thymidine Nucleotide Analogues from Blocked DNA Chains by Human Immunodeficiency Virus Reverse Transcriptase in the Presence of Physiological Concentrations of 2′-Deoxynucleoside Triphosphates
  od: Meyer, Peter R., i wsp.
  Wydane: (2000)
• Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase.
  od: Oude Essink, B B, i wsp.
  Wydane: (1997)
• Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine
  od: Bertoletti, Nicole, i wsp.
  Wydane: (2019)
• Deoxynucleoside Triphosphate Incorporation Mechanism of Foamy Virus (FV) Reverse Transcriptase: Implications for Cell Tropism of FV
  od: Santos-Velazquez, Jose, i wsp.
  Wydane: (2008)